Stocks in Focus: BioMarin Pharmaceutical Inc.

Stifel Nicolaus upgraded shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) from a hold rating to a buy rating in a report released on Tuesday, The Fly reports. The brokerage currently has $105.00 price objective on the stock. The analysts noted that the move was a valuation call.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) belongs to Healthcare sector. Its net profit margin is -34.70% and weekly performance is 1.82%. On last trading day company shares ended up at $75.61. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) distance from 50-day simple moving average (SMA50) is -3.18%.

On 16 February, Celator Pharmaceuticals, Inc. (NASDAQ:CPXX) announced that the Phase 3 clinical trial of VYXEOS™ Liposome for Injection (also known as CPX-351) in patients with untreated high-risk (secondary) acute myeloid leukemia (AML) has reached its pre-specified number of events required for the analysis of overall survival. The company expects to announce overall survival results later this quarter.

Celator Pharmaceuticals, Inc. (NASDAQ:CPXX) shares fell -4.22% in last trading session and ended the day at $2.27. CPXX return on assets is -53.40%. Celator Pharmaceuticals, Inc. (NASDAQ:CPXX) quarterly performance is 34.72%.

On 21 Februay, The Coca-Cola Company (NYSE:KO) said Consumers are in for a new experience as Coca-Cola moves to harmonise products under one umbrella, offering consumers’ choice with more clarity.

The Coca-Cola Company (NYSE:KO) belongs to Consumer Goods sector. Its net profit margin is 16.60% and weekly performance is 0.76%. On last trading day company shares ended up at $43.69. The Coca-Cola Company (NYSE:KO) distance from 50-day simple moving average (SMA50) is 2.40%.

ConocoPhillips (NYSE:COP) said it is lowering its dividend to 25 cents per share from 74 cents per share. The dividend is payable on March 1 to shareholders of record on Feb. 16. The company also reduced its 2016 capital expenditures outlook and operating cost guidance.

ConocoPhillips (NYSE:COP) shares decreased -4.44% in last trading session and ended the day at $32.92. COP Gross Margin is 33.80% and its return on assets is -4.00%. ConocoPhillips (NYSE:COP) quarterly performance is -38.06%.

On 11 February, ArcelorMittal SA (ADR) (NYSE:MT) is looking to close finishing lines at ArcelorMittal Indiana Harbor to address the overcapacity that’s been nagging the domestic steel industry.

On 23 February, ArcelorMittal SA (ADR) (NYSE:MT) shares decreased -5.82% and was closed at $3.56. MT EPS growth in last 5 year was -33.90%. ArcelorMittal SA (ADR) (NYSE:MT) year to date (YTD) performance is -15.64%.

Leave a Reply

Your email address will not be published. Required fields are marked *